Literature DB >> 11585393

MRI contrast agents for evaluating focal hepatic lesions.

M G Harisinghani1, K S Jhaveri, R Weissleder, W Schima, S Saini, P F Hahn, P R Mueller.   

Abstract

Contrast-enhanced magnetic resonance imaging (MRI) has become an important tool in the detection and characterization of focal hepatic lesions especially when other investigations such as ultrasound (US) and computed tomography (CT) are inconclusive. The purpose of this pictorial review is to briefly summarize the properties of various MRI contrast agents used in hepatic imaging and to highlight their role in evaluation of focal hepatic lesions. Copyright 2001 The Royal College of Radiologists.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585393     DOI: 10.1053/crad.2001.0764

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  6 in total

Review 1.  Focal liver lesions found incidentally.

Authors:  Abdullah A Algarni; Abdullah H Alshuhri; Majed M Alonazi; Moustafa Mabrouk Mourad; Simon R Bramhall
Journal:  World J Hepatol       Date:  2016-03-28

Review 2.  Molecular imaging: current status and emerging strategies.

Authors:  M A Pysz; S S Gambhir; J K Willmann
Journal:  Clin Radiol       Date:  2010-07       Impact factor: 2.350

3.  Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging.

Authors:  Wenbin Lin; Taeghwan Hyeon; Gregory M Lanza; Miqin Zhang; Thomas J Meade
Journal:  MRS Bull       Date:  2009-06       Impact factor: 6.578

4.  Nanoparticles for Improving Cancer Diagnosis.

Authors:  Hongmin Chen; Zipeng Zhen; Trever Todd; Paul K Chu; Jin Xie
Journal:  Mater Sci Eng R Rep       Date:  2013-03       Impact factor: 36.214

5.  Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.

Authors:  Simone Maurea; Pier Paolo Mainenti; Annamaria Tambasco; Massimo Imbriaco; Carmine Mollica; Ettore Laccetti; Luigi Camera; Raffaele Liuzzi; Marco Salvatore
Journal:  Quant Imaging Med Surg       Date:  2014-06

Review 6.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.